Summary
Respiratory Syncytial Virus (RSV) causes severe disease in the very young and elderly and results in substantial healthcare costs. In the last 4 years, substantial progress has been made in development of products for active and passive immunisation against RSV, with 19...
More information & hyperlinks
Web resources: | https://imi-promise.eu/ |